Takeda boosts profit margins with AI-driven growth, FY2024 guidance upgrade, share buyback plan & promising drug launches.

The limited time for discussions with agencies is a barrier, especially during early development, said Shirley Bartido, director of Global Regulatory Affairs Oncology Cell Therapy at Takeda ...

Nike Inc. (NKE) reported its third-quarter 2025 earnings, surpassing expectations with an earnings per share (EPS) of $0.54 against a forecast of $0.30. Despite this positive earnings surprise ...

Q3 revenue stood at $4.8 billion, down from $5.1 billion, marking a 5% decrease. Adjusted EPS fell by 15% to $1.00, driven by lower operating profit and a higher effective tax rate. Gross margin ...

Utilizing subsequent definitions of the quartiles, subjects were divided into different categories relying on their AIP values: Q1 (AIP < -0.077), Q2 (AIP -0.077 to <0.127), Q3 (AIP -0.127 to < 0.348) ...

Recent financial results showcased robust growth, with net income for Q3 2025 jumping significantly year-over-year and sales continuing to rise. Despite a write-off of RMB 6,171 million ...

Analysts expect Nike to report Q3 FY25 earnings per share (EPS) of $0.30, reflecting a 69% year-over-year decline due to multiple challenges. Nike Under Pressure Nike’s Q3 FY25 bottom line is ...

A Boston biotech try­ing to bring trans­fer RNA (tR­NA) bi­ol­o­gy to the drug de­vel­op­ment field has shut­tered op­er­a­tions, End­points News has learned.

Nike is likely to report a sales decline of 12% and gross margins contraction to 41.5%. While continued challenges are likely to impact FY26 guidance, tariffs are unlikely to have a direct impact ...

General Mills, Inc. GIS is likely to register a decline in its top and bottom lines when it reports third-quarter fiscal 2025 earnings on March 19. The Zacks Consensus Estimate for revenues is ...

There have been several high-profile deals between big pharma companies and ADC specialists in recent years. Image credit: Shutterstock/ afry_harvy. Taiho Pharmaceutical has agreed to acquire ...